<DOC>
	<DOCNO>NCT02561117</DOCNO>
	<brief_summary>The objective study determine whether administer once-daily dos metronidazole , intravenous ( IV ) antibiotic use prevent infection perforate appendicitis , effective child deliver standard method every eight hour . Reducing frequency administration potential decrease personnel time healthcare cost increase lifespan IV line . To determine effectiveness once-daily administration , randomize control trial ( RCT ) conduct compare outcomes two treatment schedule . We recruit 100 patient ( 50 per treatment ) age 5-18 surgically treat perforate appendicitis Children 's Hospital Eastern Ontario , randomly assign one two treatment schedule . To compare efficacy treatment , outcome duration hospital stay theoretical cost measure analyzed use statistical test .</brief_summary>
	<brief_title>Once Daily Metronidazole Perforated Appendicitis</brief_title>
	<detailed_description />
	<mesh_term>Appendicitis</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>All child 518 year age , present CHEO perforate appendicitis ( confirm either operate room diagnose preoperatively accord radiological criterion ) , manage surgically assess eligibility participate . These patient may participate baseline lab value serum AST ( SGOT ) , AL T ( SGPT ) , LDH , triglycerides hexokinase glucose normal , complete physical exam normal , hGC test negative pregnancy ( patient female reproductive age ) none exclusion criterion present . Any known coexisting gastrointestinal disease Uncertainty diagnosis Perforated appendicitis diffuse abdominal fluid imaging associate clinical picture severe sepsis A known allergy antibiotic use trial An active neurological disorder Receiving medical treatment neurological disorder A history blood dyscrasia , hypothyroidism hypoadrenalism Hepatic disease Renal impairment Patients receive oral intravenous concomitant antimicrobial enrollment Pregnancy Under five year age Patients receive metronidazole orally intravenously last 14 day , prior current admission appendicitis Patients already take follow medication admission ( may interact Metronidazole stated product monograph ) : disulfiram , oral anticoagulant therapy ( warfarin type ) , phenytoin phenobarbital , vecuronium , lithium , busulfan The physician elect treat patient conservatively ( nonsurgically )</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>